Home > Insider Trading > Filing (0001181431-11-022486)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1338042	Aegerion Pharmaceuticals Inc.	AEGR	Pharmaceutical Preparations (2834)	202960116

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1314575	D Marc Beer	C/O Aegerion Pharmaceuticals, Inc. 89 Headquarters Plaza, Suite 1212 Morristown NJ 07960	Chief Executive Officer	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-04-04	4,647	$16.73	110,110	No	4	P	Direct
Common Stock	Acquisiton	2011-04-04	1,310	$16.73	111,420	No	4	P	Indirect	Roth IRA

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Indirect	Roth IRA

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	105,463	Direct

Footnotes

The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 4, 2011.
This weighted average price reflects trades in multiple transactions ranging from $16.46 per share to $16.98 per share, inclusive. Full information regarding the number of shares sold at each separate price within the range noted above will be provided upon request to the SEC staff, the issuer, or any security holder of the issuer.